MAPT and Alzheimer disease: Alzheimer’s disease (AD), also known as an irreversible neurodegenerative disorder, is specified by the deposition of beta-amyloid (Aβ) in the extracellular as well as phosphorylation of tau protein to the intracellular cells that are associated with the neuronal and synaptic loss, leading to cognitive deterioration and memory loss.